Economic impact of treating invasive mold disease with isavuconazole compared with liposomal amphotericin B in the UK

AIM: Invasive mold diseases (IMDs) are associated with significant morbidity and mortality. Approved treatments include voriconazole (VORI), liposomal amphotericin B (L-AMB), posaconazole (POSA) and isavuconazole (ISAV). A UK-based economic model was developed to explore the cost of treating IMDs wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagshaw, Emma, Enoch, David A, Blackney, Michael, Posthumus, Jan, Kuessner, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190279/
https://www.ncbi.nlm.nih.gov/pubmed/29911889
http://dx.doi.org/10.2217/fmb-2018-0119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190279/
https://www.ncbi.nlm.nih.gov/pubmed/29911889
http://dx.doi.org/10.2217/fmb-2018-0119

Ejemplares similares